These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12379327)

  • 1. Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients.
    Abe H; Kuroki M; Imakiire T; Yamauchi Y; Yamada H; Arakawa F; Kuroki M
    J Immunol Methods; 2002 Dec; 270(2):227-33. PubMed ID: 12379327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
    Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
    Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
    Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
    Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor-associated antigen depends on the domains recognized by the monoclonal antibodies used: N-terminal trimmed EpCAM-levels are much higher than untrimmed forms.
    Schmetzer O; Moldenhauer G; Nicolaou A; Schlag P; Riesenberg R; Pezzutto A
    Immunol Lett; 2012 Apr; 143(2):184-92. PubMed ID: 22387297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of the 17-1A antigen (Ep-CAM).
    Balzar M; Winter MJ; de Boer CJ; Litvinov SV
    J Mol Med (Berl); 1999 Oct; 77(10):699-712. PubMed ID: 10606205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
    Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers.
    Elia L; Mennuni C; Storto M; Podda S; Calvaruso F; Salucci V; Aurisicchio L; Scarito A; Ciliberto G; La Monica N; Palombo F
    Eur J Immunol; 2006 May; 36(5):1337-49. PubMed ID: 16619291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of interleukin-2 to human MK-1-expressing carcinoma by fusion with a single-chain Fv of anti-MK-1 antibody.
    Matsumoto H; Liao S; Arakawa F; Ueno A; Abe H; Awasthi A; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(4):2001-7. PubMed ID: 12174877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.
    Lammers R; Giesert C; Grünebach F; Marxer A; Vogel W; Bühring HJ
    Exp Hematol; 2002 Jun; 30(6):537-45. PubMed ID: 12063020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesothelin variant 1 is released from tumor cells as a diagnostic marker.
    Hellstrom I; Raycraft J; Kanan S; Sardesai NY; Verch T; Yang Y; Hellstrom KE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1014-20. PubMed ID: 16702385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues.
    Xie X; Wang CY; Cao YX; Wang W; Zhuang R; Chen LH; Dang NN; Fang L; Jin BQ
    World J Gastroenterol; 2005 Jan; 11(3):344-7. PubMed ID: 15637741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a double antibody sandwich ELISA for the detection of human sDC-SIGN.
    Chen SL; Li YL; Tang Y; Chen ZC; Zhou J; Zhou J; Lu X; Zhao N; Chen ZL; Zuo D
    J Immunol Methods; 2016 Sep; 436():16-21. PubMed ID: 27262264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identification of a human carcinoma-associated glycoprotein antigen recognized by mouse monoclonal antibody FU-MK-1.
    Tomita Y; Arakawa F; Yamamoto T; Kuwahara M; Watanabe R; Iwasaki H; Kikuchi M; Kuroki M
    Jpn J Cancer Res; 2000 Feb; 91(2):231-8. PubMed ID: 10761711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.
    Scholler N; Fu N; Yang Y; Ye Z; Goodman GE; Hellström KE; Hellström I
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11531-6. PubMed ID: 10500211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring antibodies to epithelial cell adhesion molecule (EpCAM).
    Kirman I; Jenkins D; Fowler R; Whelan RL
    Dig Dis Sci; 2003 Dec; 48(12):2306-9. PubMed ID: 14714617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.
    Kim JH; Herlyn D; Wong KK; Park DC; Schorge JO; Lu KH; Skates SJ; Cramer DW; Berkowitz RS; Mok SC
    Clin Cancer Res; 2003 Oct; 9(13):4782-91. PubMed ID: 14581349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins.
    Litvinov SV; Balzar M; Winter MJ; Bakker HA; Briaire-de Bruijn IH; Prins F; Fleuren GJ; Warnaar SO
    J Cell Biol; 1997 Dec; 139(5):1337-48. PubMed ID: 9382878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.